BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Sep 5, 2026; 17(3): 120377
Published online Sep 5, 2026. doi: 10.4292/wjgpt.120377
Figure 3
Figure 3 Comparison of overall survival benefit in studies using lenvatinib as control arm. In orange, the two lenvatinib control arms pooled together; in green, pembrolizumab + lenvatinib[9]; in blue, nivolumab + ipilimumab[5]. Time in months.


Write to the Help Desk